SMO and cholangiocarcinoma: CUR6414 directly binds to SMO to treat basal cell carcinoma [105], while BMS-833923 directly binds to SMO, reducing the growth of medulloblastoma, pancreatic cancer and cholangiocarcinoma in xenograft mice [116,126].